Home Top Movers Here is why Cellect Biotechnology Ltd. (APOP) stock shares rallied on Wednesday?

Here is why Cellect Biotechnology Ltd. (APOP) stock shares rallied on Wednesday?

Cellect Biotechnology Ltd. (APOP) surged 56.88% in the after-market session on Wednesday, June 16, 2021, and close the day at $1.86 per share. Earlier in Wednesday’s morning session, APOP stock gained 7.57% and close the morning session at $3.27 per share.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

APOP shares have risen 3.48% over the last 12 months, and they have moved up 5.48% in the past week. Over the past three months, the stock has lost 9.67%, while over the past six months, it has added 39.15%.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Filing Registration Statement

On June 16, 2021, Cellect Biotechnology Ltd filed a registration statement, including a joint proxy statement/prospectus with the Securities and Exchange Commission (SEC) in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals. The transaction is currently expected to close in the 2021 third quarter.

Read More

Top Line data results from Phase 1/2 clinical trial of ApoGraft™ technology

On April 19, 2021, Cellect Biotechnology Ltd reported positive data from the Company’s open-label Phase 1/2 clinical trial of its ApoGraft™ technology in Israel.

All eleven patients in the trial were engrafted promptly by using the ApoGraft product. The primary objective, safety, and tolerability were met and there were no procedure-related adverse events.

Q4 & FY 2020 financial results announcement

On March 29, 2021, Cellect Biotechnology Ltd released its financial and operating results for the fourth quarter and full-year ended December 31, 2020.

Q4 2020 financial highlights

  • Research and development (R&D) expenses for the fourth quarter were $0.53 million compared to $0.80 million in Q 4 2019.
  • The company suffered a comprehensive loss of $1.58 million or $0.004 per share in Q4 2020 compared to $1.89 million, or $0.008 per share, in the fourth quarter of 2019.
  • General and administrative (G&A) expenses for the fourth quarter were $0.67 million compared to $0.74 million in the fourth quarter of 2019.
  • Finance expenses for the fourth quarter of 2020 were $0.38 million compared to finance expenses of $0.35 million in the fourth quarter of 2019.

FY 2020 financial highlights

  • Research and development (R&D) expenses for the year 2020 were $1.83 million compared to$3.77 million for FY 2019.
  • The company suffered a comprehensive loss of $5.62 million or $0.015 per share in FY 2020 compared to $5.23 million, or $0.025 per share, for the full year of 2019.
  • General and administrative (G&A) expenses for the full year of 2020 were $2.52 million, compared to $3.18 million for the full year of 2019.
  • Financial expenses were $1.27 million for the full year of 2020, compared to financial income of $1.72 million for the full year of 2019.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

The filing of the registration statement could be the reason behind its exceptional performance on Wednesday as it can be seen as a major step towards the completion of the announced merger.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Helix Energy Solutions Inc. (HLX) stock fell during pre-market. What’s behind this decline?

Helix Energy Solutions Group Inc. (HLX) stock gained by 4.54% at the last close whereas the HLX stock price plunged by 6.72% in the...

F5 Networks Inc. (FFIV) stock soars during pre-market trading. Here’s to know why?

F5 Networks Inc. (FFIV) stock gained by 0.23% at the last close while the FFIV stock surged by 6.05% in the pre-market trading session....

Related News

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

F5 Networks Inc. (FFIV) stock soars during pre-market trading. Here’s to know why?

F5 Networks Inc. (FFIV) stock gained by 0.23% at the last close while the FFIV stock surged by 6.05% in the pre-market trading session....

Here is why Cerecor Inc. (CERC) stock turnaround in the after-hours on Monday?

Cerecor Inc. (CERC) shares gained 12.23% in after-hours on Monday, July 26, 2021, and closed the trading at $3.12. in the regular trading session,...

Here is why Bit Digital Inc. (BTBT) stock skyrocketed on Monday?

Bit Digital Inc. (BTBT) shares declined 10.94% in after-hours on Monday, July 26, 2021, and closed the day at $7.90. Earlier in the regular...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam